Vaccine Contract Manufacturing Market By Vaccine Type (Inactivated Vaccines, Attenuated Vaccines, RNA Vaccines, Subunit Vaccines, and Toxoid-based Vaccines), By Process (Downstream (Analytical & QC Studies, Fill and Finish, Packaging, Others) and Upstream (Bacterial Expression Systems, Baculovirus/Insect Expression Systems, Mammalian Expression Systems, Yeast Expression Systems, Others)), By Scale of Operations (Preclinical, Clinical, and Commercial), By End-use (Human Use and Veterinary), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Vaccine Contract Manufacturing Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of Vaccine Contract Manufacturing Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Vaccine Contract Manufacturing Market Analysis and Forecast, By Segment, 2019-2033
  • 3.1. Key Findings
  • 3.2. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  • 3.3. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
    • 3.3.1. Inactivated Vaccines
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Attenuated Vaccines
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
    • 3.3.3. RNA Vaccines
      • 3.3.3.1. Insights
      • 3.3.3.2. Key Takeaways
    • 3.3.4. Subunit Vaccines
      • 3.3.4.1. Insights
      • 3.3.4.2. Key Takeaways
    • 3.3.5. Toxoid-based Vaccines
      • 3.3.5.1. Insights
      • 3.3.5.2. Key Takeaways
  • 3.4. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  • 3.5. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
    • 3.5.1. Downstream
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
        • 3.5.1.2.1. Analytical & QC Studies
        • 3.5.1.2.2. Fill and Finish
        • 3.5.1.2.3. Packaging
        • 3.5.1.2.4. Others
    • 3.5.2. Upstream
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
        • 3.5.2.2.1. Bacterial Expression Systems
        • 3.5.2.2.2. Baculovirus/Insect Expression Systems
        • 3.5.2.2.3. Mammalian Expression Systems
        • 3.5.2.2.4. Yeast Expression Systems
        • 3.5.2.2.5. Others
  • 3.6. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  • 3.7. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
    • 3.7.1. Preclinical
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Clinical
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Commercial
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
  • 3.8. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  • 3.9. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
    • 3.9.1. Human Use
      • 3.9.1.1. Insights
      • 3.9.1.2. Key Takeaways
    • 3.9.2. Veterinary
      • 3.9.2.1. Insights
      • 3.9.2.2. Key Takeaways
• 4. Global Vaccine Contract Manufacturing Market Analysis and Forecast, By Region, 2019-2033
  • 4.1. Key Findings
  • 4.2. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Region
• 5. North America Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  • 5.1. Key Findings
  • 5.2. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  • 5.3. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  • 5.4. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  • 5.5. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  • 5.6. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  • 5.7. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  • 5.8. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  • 5.9. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  • 5.10. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 5.11. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    • 5.11.1. The US
    • 5.11.2. Canada
• 6. Europe Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  • 6.1. Key Findings
  • 6.2. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  • 6.3. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  • 6.4. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  • 6.5. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  • 6.6. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  • 6.7. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  • 6.8. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  • 6.9. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  • 6.10. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 6.11. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    • 6.11.1. Germany
    • 6.11.2. The UK
    • 6.11.3. France
    • 6.11.4. Spain
    • 6.11.5. Italy
    • 6.11.6. Russia
    • 6.11.7. Netherland
    • 6.11.8. Rest of Europe
• 7. Asia Pacific Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  • 7.1. Key Findings
  • 7.2. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  • 7.3. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  • 7.4. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  • 7.5. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  • 7.6. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  • 7.7. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  • 7.8. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  • 7.9. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  • 7.10. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 7.11. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    • 7.11.1. China
    • 7.11.2. Japan
    • 7.11.3. South Korea
    • 7.11.4. India
    • 7.11.5. Australia
    • 7.11.6. New Zealand
    • 7.11.7. Singapore
    • 7.11.8. Thailand
    • 7.11.9. Vietnam
    • 7.11.10. Rest of Asia Pacific
• 8. Latin America Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  • 8.1. Key Findings
  • 8.2. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  • 8.3. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  • 8.4. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  • 8.5. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  • 8.6. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  • 8.7. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  • 8.8. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  • 8.9. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  • 8.10. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 8.11. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    • 8.11.1. Brazil
    • 8.11.2. Mexico
    • 8.11.3. Rest of Latin America
• 9. Middle East & Africa Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  • 9.3. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  • 9.4. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  • 9.5. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  • 9.6. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  • 9.7. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  • 9.8. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  • 9.9. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  • 9.10. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 9.11. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    • 9.11.1. South Africa
    • 9.11.2. Saudi Arabia
    • 9.11.3. UAE
    • 9.11.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
    • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. PRA Health Sciences
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. Pharmaceutical Product Development, LLC
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Moderna
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Merck KgaA
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. IDT Biologika GmbH
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. ICON plc.
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. Cytovance Biologics
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Cobra Bio
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
    • 10.7.9. Catalent, Inc.
      • 10.7.9.1. Company Details
      • 10.7.9.2. Business Overview
      • 10.7.9.3. Product Portfolio
      • 10.7.9.4. Financial Insights
      • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.9.6. SWOT Analysis
      • 10.7.9.7. Geographic Footprint
    • 10.7.10. Ajinomoto Althea, Inc.
      • 10.7.10.1. Company Details
      • 10.7.10.2. Business Overview
      • 10.7.10.3. Product Portfolio
      • 10.7.10.4. Financial Insights
      • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.10.6. SWOT Analysis
      • 10.7.10.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 2. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 3. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 4. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 5. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By Region, 2019-2033
• Table 6. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 7. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 8. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 9. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 10. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
• Table 11. The US Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 12. The US Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 13. The US Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 14. The US Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 15. Canada Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 16. Canada Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 17. Canada Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 18. Canada Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 19. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 20. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 21. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 22. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 23. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
• Table 24. Germany Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 25. Germany Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 26. Germany Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 27. Germany Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 28. The UK Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 29. The UK Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 30. The UK Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 31. The UK Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 32. France Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 33. France Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 34. France Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 35. France Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 36. Spain Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 37. Spain Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 38. Spain Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 39. Spain Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 40. Italy Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 41. Italy Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 42. Italy Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 43. Italy Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 44. Russia Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 45. Russia Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 46. Russia Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 47. Russia Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 48. Netherland Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 49. Netherland Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 50. Netherland Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 51. Netherland Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 52. Rest of Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 53. Rest of Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 54. Rest of Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 55. Rest of Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 56. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 57. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 58. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 59. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 60. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
• Table 61. China Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 62. China Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 63. China Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 64. China Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 65. India Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 66. India Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 67. India Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 68. India Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 69. Japan Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 70. Japan Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 71. Japan Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 72. Japan Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 73. South Korea Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 74. South Korea Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 75. South Korea Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 76. South Korea Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 77. Australia Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 78. Australia Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 79. Australia Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 80. Australia Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 81. New Zealand Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 82. New Zealand Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 83. New Zealand Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 84. New Zealand Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 85. Singapore Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 86. Singapore Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 87. Singapore Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 88. Singapore Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 89. Thailand Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 90. Thailand Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 91. Thailand Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 92. Thailand Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 93. Vietnam Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 94. Vietnam Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 95. Vietnam Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 96. Vietnam Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 97. Rest of Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 98. Rest of Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 99. Rest of Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 100. Rest of Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 101. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 102. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 103. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 104. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 105. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
• Table 106. Brazil Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 107. Brazil Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 108. Brazil Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 109. Brazil Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 110. Mexico Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 111. Mexico Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 112. Mexico Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 113. Mexico Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 114. Rest of Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 115. Rest of Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 116. Rest of Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 117. Rest of Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 118. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 119. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 120. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 121. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 122. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
• Table 123. South Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 124. South Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 125. South Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 126. South Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 127. Saudi Arabia Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 128. Saudi Arabia Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 129. Saudi Arabia Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 130. Saudi Arabia Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 131. UAE Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 132. UAE Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 133. UAE Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 134. UAE Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
• Table 135. Rest of Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
• Table 136. Rest of Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
• Table 137. Rest of Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
• Table 138. Rest of Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033

List of Figures

• Figure 1. Global Vaccine Contract Manufacturing Market Snapshot: Market Value (US$ Mn), 2019-2033
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Vaccine Contract Manufacturing Market
• Figure 5. Global Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
• Figure 6. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
• Figure 7. Global Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
• Figure 8. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
• Figure 9. Global Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
• Figure 10. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
• Figure 11. Global Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 12. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
• Figure 13. Global Vaccine Contract Manufacturing Market Analysis, By Region, 2019, 2023 and 2033
• Figure 14. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Region
• Figure 15. North America Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
• Figure 16. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
• Figure 17. North America Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
• Figure 18. North America Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
• Figure 19. North America Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
• Figure 20. North America Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
• Figure 21. North America Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
• Figure 22. North America Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
• Figure 23. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
• Figure 24. North America Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
• Figure 25. North America Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
• Figure 26. North America Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
• Figure 27. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
• Figure 28. North America Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
• Figure 29. North America Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
• Figure 30. North America Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
• Figure 31. North America Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 32. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
• Figure 33. North America Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
• Figure 34. North America Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
• Figure 35. North America Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
• Figure 36. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 37. Europe Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
• Figure 38. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
• Figure 39. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
• Figure 40. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
• Figure 41. Europe Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
• Figure 42. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
• Figure 43. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
• Figure 44. Europe Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
• Figure 45. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
• Figure 46. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
• Figure 47. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
• Figure 48. Europe Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
• Figure 49. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
• Figure 50. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
• Figure 51. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
• Figure 52. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
• Figure 53. Europe Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 54. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
• Figure 55. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
• Figure 56. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
• Figure 57. Europe Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
• Figure 58. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 59. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
• Figure 60. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
• Figure 61. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
• Figure 62. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
• Figure 63. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
• Figure 64. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
• Figure 65. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
• Figure 66. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
• Figure 67. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
• Figure 68. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
• Figure 69. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
• Figure 70. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
• Figure 71. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
• Figure 72. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
• Figure 73. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
• Figure 74. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
• Figure 75. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 76. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
• Figure 77. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
• Figure 78. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
• Figure 79. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
• Figure 80. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 81. Latin America Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
• Figure 82. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
• Figure 83. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
• Figure 84. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
• Figure 85. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
• Figure 86. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
• Figure 87. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
• Figure 88. Latin America Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
• Figure 89. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
• Figure 90. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
• Figure 91. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
• Figure 92. Latin America Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
• Figure 93. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
• Figure 94. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
• Figure 95. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
• Figure 96. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
• Figure 97. Latin America Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 98. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
• Figure 99. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
• Figure 100. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
• Figure 101. Latin America Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
• Figure 102. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 103. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
• Figure 104. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
• Figure 105. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
• Figure 106. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
• Figure 107. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
• Figure 108. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
• Figure 109. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
• Figure 110. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
• Figure 111. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
• Figure 112. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
• Figure 113. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
• Figure 114. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
• Figure 115. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
• Figure 116. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
• Figure 117. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
• Figure 118. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
• Figure 119. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
• Figure 120. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
• Figure 121. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
• Figure 122. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
• Figure 123. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
• Figure 124. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country